Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 10—October 2011

Research

Humans Infected with Relapsing Fever Spirochete Borrelia miyamotoi, Russia

Alexander E. Platonov, Ludmila S. Karan, Nadezhda M. Kolyasnikova, Natalya A. Makhneva, Marina G. Toporkova, Victor V. Maleev, Durland Fish, and Peter J. KrauseComments to Author 

Author affiliations: Central Research Institute of Epidemiology, Moscow, Russia (A.E. Platonov, L.S. Karan, N.M. Kolyasnikova, V.V. Maleev); Municipal Clinical Hospital No. 33, Yekaterinburg, Russia (N.A. Makhneva, M.G. Toporkova); Yale School of Public Health and Yale School of Medicine, New Haven, Connecticut, USA (D. Fish, P.J. Krause)

Main Article

Table 2

Patient characteristics and infection timeline for Borrelia spp. infections, by species*

Borrelia species No. patients infected Infection timeline, median no. days (IQR)
Patient characteristics
Tick bite to symptom onset Symptom onset to hospital admission
Median age, y (range) Male sex, no. (%)
B. miyamotoi 46 54 (21–77) 24 (52) 15 (12–16) 1 (1–2)
B. garinii 21 58 (18–87) 11 (52) 10 (7–13)† 5 (2–9)†
B. burgdorferi 92 50 (14–79) 49 (53) NA NA

*IQR, interquartile range; NA, not available.
†p<0.001 in comparison with patients with B. miyamotoi infection.

*IQR, interquartile range; NA, not available.
†p<0.001 in comparison with patients with B. miyamotoi infection.

*IQR, interquartile range; NA, not available.
†p<0.001 in comparison with patients with B. miyamotoi infection.

*IQR, interquartile range; NA, not available.
†p<0.001 in comparison with patients with B. miyamotoi infection.

*IQR, interquartile range; NA, not available.
†p<0.001 in comparison with patients with B. miyamotoi infection.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO